Antitumour efficacy of the selumetinib and trametinib MEK inhibitors in a combined human airway-tumour-stroma lung cancer model.
Mas, Christophe
Antitumour efficacy of the selumetinib and trametinib MEK inhibitors in a combined human airway-tumour-stroma lung cancer model. [electronic resource] - Journal of biotechnology Jul 2015 - 111-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-4863
10.1016/j.jbiotec.2015.01.012 doi
Benzimidazoles--pharmacology
Cell Proliferation--drug effects
Cells, Cultured
Drug Screening Assays, Antitumor--methods
Epithelial Cells--cytology
Fibroblasts--cytology
Humans
Lung--cytology
Lung Neoplasms--drug therapy
Models, Biological
Protein Kinase Inhibitors--pharmacology
Pyridones--pharmacology
Pyrimidinones--pharmacology
Tumor Microenvironment--drug effects
Antitumour efficacy of the selumetinib and trametinib MEK inhibitors in a combined human airway-tumour-stroma lung cancer model. [electronic resource] - Journal of biotechnology Jul 2015 - 111-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-4863
10.1016/j.jbiotec.2015.01.012 doi
Benzimidazoles--pharmacology
Cell Proliferation--drug effects
Cells, Cultured
Drug Screening Assays, Antitumor--methods
Epithelial Cells--cytology
Fibroblasts--cytology
Humans
Lung--cytology
Lung Neoplasms--drug therapy
Models, Biological
Protein Kinase Inhibitors--pharmacology
Pyridones--pharmacology
Pyrimidinones--pharmacology
Tumor Microenvironment--drug effects